Search

Search Constraints

You searched for: Author/Creator Carbone, David P.

Search Results

2. The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management ofEGFRMutation–Positive Non–Small Cell Lung Cancer: Status in 2016. Issue 7 (July 2016)

3. Relationship between Overall Survival and Response or Progression‐Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD‐1/PD‐L1 Antibodies. Issue 11 (November 2016)

5. Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater. (December 2019)

8. Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib. (March 2020)

9. Real-world insights into patients with advanced NSCLC and MET alterations. (September 2021)